Web10 de abr. de 2024 · Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates. Onconova Therapeutics, Inc. (ONTX) delivered earnings and revenue … WebOnconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage …
Yahoo Finance
Web11 de abr. de 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Onconova Therapeutics stock is Buy based on the current 1 buy rating for ONTX. The average twelve-month price prediction for Onconova Therapeutics is $11.00 with a high price target of $11.00 and a low price target of $11.00. WebFind the latest ON24, Inc. (ONTF) stock quote, history, news and other vital information to help you with your stock trading and investing. chugach government solutions anchorage
National Instruments (NASDAQ:NATI) Research Coverage Started …
Web17 de mar. de 2024 · Amid risk-on sentiment, penny stocks are surging higher today as investors seek to grab the higher upside these small-cap stocks provide. ... Top Penny Stocks News Today: TNXP, ONTX, AREC, ... Web24 de mar. de 2024 · Company Description. Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological ... WebOnconova Therapeutics, Inc. (ONTX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 0.7000 -0.0100 (-1.41%) At close: 04:00PM EDT. 0.6900 … chugach government solutions linthicum md